Using geospatial models to map zero-dose children: factors associated with zero-dose vaccination status before and after a mass measles and rubella vaccination campaign in Southern province, Zambia.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
12 2021
Historique:
received: 18 09 2021
accepted: 07 12 2021
entrez: 31 12 2021
pubmed: 1 1 2022
medline: 19 3 2022
Statut: ppublish

Résumé

Despite gains in global coverage of childhood vaccines, many children remain undervaccinated. Although mass vaccination campaigns are commonly conducted to reach these children their effectiveness is unclear. We evaluated the effectiveness of a mass vaccination campaign in reaching zero-dose children. We conducted a prospective study in 10 health centre catchment areas in Southern province, Zambia in November 2020. About 2 months before a national mass measles and rubella vaccination campaign conducted by the Ministry of Health, we used aerial satellite maps to identify built structures. These structures were visited and diphtheria-tetanus-pertussis (DTP) and measles zero-dose children were identified (children who had not received any DTP or measles-containing vaccines, respectively). After the campaign, households where measles zero-dose children were previously identified were targeted for mop-up vaccination and to assess if these children were vaccinated during the campaign. A Bayesian geospatial model was used to identify factors associated with zero-dose status and measles zero-dose children being reached during the campaign. We also produced fine-scale zero-dose prevalence maps and identified optimal locations for additional vaccination sites. Before the vaccination campaign, 17.3% of children under 9 months were DTP zero-dose and 4.3% of children 9-60 months were measles zero-dose. Of the 461 measles zero-dose children identified before the vaccination campaign, 338 (73.3%) were vaccinated during the campaign and 118 (25.6%) were reached by a targeted mop-up activity. The presence of other children in the household, younger age, greater travel time to health facilities and living between health facility catchment areas were associated with zero-dose status. Mapping zero-dose prevalence revealed substantial heterogeneity within and between catchment areas. Several potential locations were identified for additional vaccination sites. Fine-scale variation in zero-dose prevalence and the impact of accessibility to healthcare facilities on vaccination coverage were identified. Geospatial modelling can aid targeted vaccination activities.

Identifiants

pubmed: 34969682
pii: bmjgh-2021-007479
doi: 10.1136/bmjgh-2021-007479
pmc: PMC8719156
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NLM NIH HHS
ID : DP2 LM013102
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Sci Rep. 2020 Jun 25;10(1):10307
pubmed: 32587283
Trop Med Int Health. 2012 Jun;17(6):697-710
pubmed: 22943300
Food Nutr Bull. 2010 Sep;31(3 Suppl):S248-63
pubmed: 21049845
Malar J. 2018 Feb 23;17(1):93
pubmed: 29471832
Vaccine. 2021 Mar 1;39(9):1359-1363
pubmed: 33551302
Epidemiology. 2010 May;21(3):383-8
pubmed: 20335814
J Trop Pediatr. 2006 Oct;52(5):324-8
pubmed: 16401614
BMC Public Health. 2008 May 16;8:161
pubmed: 18485194
Nature. 2018 Jan 18;553(7688):333-336
pubmed: 29320477
Nature. 2015 Oct 8;526(7572):207-211
pubmed: 26375008
Vaccine. 2011 Nov 21;29(50):9298-302
pubmed: 22015393
Nature. 1985 Nov 28-Dec 4;318(6044):323-9
pubmed: 3906406
Vaccine. 2011 Oct 26;29(46):8215-21
pubmed: 21893149
Proc Biol Sci. 2006 Nov 7;273(1602):2743-8
pubmed: 17015324
MMWR Morb Mortal Wkly Rep. 2000 Nov 13;69(45):1706-1710
pubmed: 33187395
Int J Health Policy Manag. 2018 Dec 30;8(4):211-221
pubmed: 31050966
BMC Public Health. 2006 May 17;6:132
pubmed: 16707013
Vaccine. 2018 Jan 2;36(1):170-178
pubmed: 29174680
BMJ Glob Health. 2021 Jan;6(1):
pubmed: 33495286
Vaccine. 2021 Aug 9;39(34):4895-4902
pubmed: 33744047
Vaccine. 2021 Jul 22;39(32):4564-4570
pubmed: 33744046
Lancet. 2021 Aug 7;398(10299):522-534
pubmed: 34273292
Lancet. 2021 Aug 7;398(10299):503-521
pubmed: 34273291

Auteurs

Rohan Arambepola (R)

Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Yangyupei Yang (Y)

International Vaccine Access Center, International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Kyle Hutchinson (K)

Implementation Science, Akros Zamba, Lusaka, Zambia.

Francis Dien Mwansa (FD)

Directorate of Public Health and Research, Zambia Ministry of Health, Lusaka, Zambia.

Julie Ann Doherty (JA)

Implementation Science, Akros Zamba, Lusaka, Zambia.

Frazer Bwalya (F)

Implementation Science, Akros Zamba, Lusaka, Zambia.

Phillimon Ndubani (P)

Administration, Macha Research Trust, Choma, Zambia.

Gloria Musukwa (G)

Choma General Hospital, Zambia Ministry of Health, Lusaka, Zambia.

William John Moss (WJ)

Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
International Vaccine Access Center, International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Amy Wesolowski (A)

Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Simon Mutembo (S)

International Vaccine Access Center, International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA smutemb1@jhmi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH